GT Biopharma (GTBP) announced the appointment of Andrew Ritter to its Board of Directors. Ritter will be replacing current board member Dr. Rajesh Shrotriya, who is resigning from his position.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTBP: